Search Results - "Abramowitz, Wattanaporn"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil by Periclou, Antonia P, Ventura, Daniel, Sherman, Tyler, Rao, Niranjan, Abramowitz, Wattanaporn T

    Published in The Annals of pharmacotherapy (01-09-2004)
    “…BACKGROUND: Memantine, a low- to moderate-affinity, uncompetitive N-methyl-d-aspartate receptor antagonist, was approved in the US for treatment of moderate to…”
    Get full text
    Journal Article
  2. 2

    An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir by Gutierrez, Marcelo M., Rosenberg, Jeffrey, Abramowitz, Wattanaporn

    Published in Clinical therapeutics (01-04-2003)
    “…Background: Depression often coexists with a number of disease states, and patients with a diagnosis of depression often receive multiple medications. Thus, it…”
    Get full text
    Journal Article
  3. 3

    Lack of Effect of a Single Dose of Ketoconazole on the Pharmacokinetics of Citalopram by Gutierrez, Marcelo, Abramowitz, Wattanaporn

    Published in Pharmacotherapy (01-02-2001)
    “…Study Objective. To determine whether the pharmacokinetics of the antidepressant citalopram are affected by ketoconazole, a potent inhibitor of cytochrome P450…”
    Get full text
    Journal Article
  4. 4

    Lack of Interaction Between Citalopram and the CYP3A4 Substrate Triazolam by Nolting, Arno, Abramowitz, Wattanaporn

    Published in Pharmacotherapy (01-07-2000)
    “…Study Objectives. To determine the effect of the selective serotonin reuptake inhibitor citalopram on plasma levels of triazolam, and to determine the effect…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetic study of memantine in healthy and renally impaired subjects by Periclou, Antonia, Ventura, Daniel, Rao, Niranjan, Abramowitz, Wattanaporn

    Published in Clinical pharmacology and therapeutics (01-01-2006)
    “…Objective Our objective was to evaluate the pharmacokinetics of the Alzheimer's disease treatment memantine in subjects with normal and impaired renal…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: A single-center, multiple-dose, open-label study by Rao, Niranjan, Chou, Thomas, Ventura, Daniel, Abramowitz, Wattanaporn

    Published in Clinical therapeutics (01-10-2005)
    “…The high prevalence rates of both 1026 Alzheimer's disease (AD) and type 2 diabetes mellitus in the elderly population suggest that concomitant pharmacotherapy…”
    Get full text
    Journal Article
  8. 8

    Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide by Nolting, Arno, Sista, Suryanarayana, Abramowitz, Wattanaporn

    Published in Journal of pharmaceutical sciences (01-02-2002)
    “…The hydrofluoroalkane (HFA) formulation of the inhaled corticosteroid flunisolide is a modification of the original chlorofluorocarbon (CFC) formulation. HFA…”
    Get more information
    Journal Article
  9. 9

    Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: Two randomized, open-label, crossover studies in healthy adult volunteers by Kapil, Ram, Nolting, Arno, Roy, Partha, Fiske, William, Benedek, Irma, Abramowitz, Wattanaporn

    Published in Clinical therapeutics (01-12-2004)
    “…As part of ongoing studies to evaluate the analgesic efficacy and pharmacokinetic properties of combination oxycodone plus ibuprofen in the treatment of…”
    Get full text
    Journal Article
  10. 10

    Steady-State Pharmacokinetics of Citalopram in Young and Elderly Subjects by Gutierrez, Marcelo, Abramowitz, Wattanaporn

    Published in Pharmacotherapy (01-12-2000)
    “…Study Objectives. To compare the steady‐state pharmacokinetics of citalopram after multiple‐dose administration in elderly and young subjects, and to correlate…”
    Get full text
    Journal Article
  11. 11

    Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide by Jakate, Abhijeet S., Roy, Partha, Patel, Alpita, Abramowitz, Wattanaporn, Persiani, Stefano, Wangsa, Julie, Kapil, Ram

    Published in British journal of clinical pharmacology (01-11-2005)
    “…Aims Dexloxiglumide is a new CCK1 receptor antagonist under investigation for treatment of functional gastrointestinal disorders and is metabolized by CYP3A4…”
    Get full text
    Journal Article
  12. 12

    Pharmacokinetic comparison of oral solution and tablet formulations of citalopram: a single-dose, randomized, crossover study by Gutierrez, Marcelo M., Abramowitz, Wattanaporn

    Published in Clinical therapeutics (01-12-2000)
    “…Background: Citalopram tablets fulfill most dosing needs in the treatment of depression, but some patients may have difficulty swallowing tablets and thus may…”
    Get full text
    Journal Article
  13. 13

    Multiple-dose proportionality study of flunisolide hydrofluoroalkane by Nolting, Arno, Abramowitz, Wattanaporn

    Published in Allergy and asthma proceedings (01-09-2002)
    “…The hydrofluoroalkane (HFA) formulation of the inhaled corticosteroid flunisolide is a modification of the original chlorofluorocarbon formulation. HFA…”
    Get more information
    Journal Article
  14. 14

    Effect of Multiple-Dose Dexloxiglumide on the Pharmacokinetics of Oral Contraceptives in Healthy Women by Roy, Partha, Jakate, Abhijeet S., Patel, Alpita, Abramowitz, Wattanaporn, Wangsa, Julie, Persiani, Stefano, Kapil, Ram

    Published in Journal of clinical pharmacology (01-03-2005)
    “…This study was undertaken to evaluate the effect of dexloxiglumide, a selective cholecystokinin receptor antagonist, on the pharmacokinetics of a combination…”
    Get full text
    Journal Article
  15. 15

    Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers by Nolting, Arno, Sista, Suryanarayana, Abramowitz, Wattanaporn

    Published in Biopharmaceutics & drug disposition (01-12-2001)
    “…Two preparations of flunisolide, an inhaled corticosteroid, were compared in a parallel, multiple‐dose study of 31 healthy volunteers. The new flunisolide…”
    Get full text
    Journal Article
  16. 16

    Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration by Dickens, G R, Wermeling, D P, Matheny, C J, John, W, Abramowitz, W, Sista, S M, Foster, T, Choudhury, S

    Published in Annals of allergy, asthma, & immunology (01-05-2000)
    “…After inhalation of a glucocorticoid from a meter dose inhaler (MDI), a certain portion of the delivered dose is deposited in the lungs, and the remainder is…”
    Get more information
    Journal Article
  17. 17

    Gastrointestinal transit of nondisintegrating, nonerodible oral dosage forms in pigs by MOHAMMAD HOSSAIN, ABRAMOWITZ, W, WATROUS, B. J, SZPUNAR, G. J, AYRES, J. W

    Published in Pharmaceutical research (01-11-1990)
    “…Gastrointestinal (GI) transit data necessary as "baseline" or "control" information were collected using pigs as animal models preliminary to bioavailability…”
    Get full text
    Journal Article
  18. 18

    Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants by Richards, J, Hirst, P, Pitcairn, G, Mahashabde, S, Abramowitz, W, Nolting, A, Newman, S P

    Published in Journal of aerosol medicine (01-06-2001)
    “…Our objective was to assess the deposition and pharmacokinetics of a novel formulation of flunisolide (Aerobid, Forest Laboratories) in hydrofluoroalkane (HFA)…”
    Get more information
    Journal Article